These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Offit worries that the cancellation of the FDA's flu vaccine meeting, held every March for at least 30 years, is just the ...

Each adult and adolescent participant in the open-label Phase II study ... of obtaining approval for a 2-dose vial KOSTAIVE vaccine targeting the latest COVID strains. I will now provide a quick ...

Joseph Payne; President, Chief Executive Officer, Director; Arcturus Therapeutics Holdings Inc Andrew Sassine; Chief Financial Officer, Director; Arcturus Therapeutics Holdings Inc Padmanabh ...

Otulfi is available in subcutaneous and intravenous formulations as 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL single dose vial for IV infusion. Otulfi in ...

Roche also will be introducing a new 25-mg vial configuration in the coming months ... Genentech explained. The label recommends initiating treatment as soon as possible and within three hours ...

With Mardi Gras' second weekend getting underway tonight and Spring Break barely a week away, Galveston County's top health official is on "pins and needles" when eyeing the growing measles ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review the ...